Home › Neuroendocrine Tumors › Louisiana › Metairie
Neuroendocrine Tumors clinical trials in Metairie, LA
3 studies for Neuroendocrine Tumors are looking for participants at sites in and around Metairie (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- East Jefferson General Hospital, Metairie
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
RecruitingPhase 3
- Louisiana State University Health Sciences, Metairie
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
RecruitingPhase 1/2
- Crinetics Study Site, Metairie
Neuroendocrine Tumors trials in other cities
- Philadelphia, PA11 studies
- Washington, DC11 studies
- Rochester, MN9 studies
- Houston, TX8 studies
- Columbus, OH7 studies
- Chicago, IL7 studies
- St. Louis, MO7 studies
- Detroit, MI7 studies
- Cleveland, OH7 studies
- Salt Lake City, UT7 studies
- Dallas, TX6 studies
- Miami, FL6 studies
Other studies in Metairie
- Prostate Cancer12 studies
- Ulcerative Colitis8 studies
- Bladder Cancer6 studies
- Obesity5 studies
- Type 2 Diabetes5 studies
- Crohn's Disease5 studies
- Steatotic Liver Disease4 studies
- Metastatic Cancer4 studies
- Cardiovascular Disease4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Urothelial (Transitional Cell) Carcinoma3 studies
- Overweight3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.